Medaxion has filed a notice of an exempt offering of securities to raise $20,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Medaxion is raising $20,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jeff McLaren played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Medaxion
Medaxion partners with hospitals and anesthesia practices to optimize OR performance and revenue. Our easy-to-use solutions and powerful intelligence capability advance clinical care, improve your financials and enhance quality whether you’re part of a large enterprise or a smaller scale organization. Our team has a combined 100+ years of experience in the anesthesia industry serving as a valuable partner to clinical, pharmacy, RCM, nursing and executive teams. Medaxion solutions deliver clear, complete anesthesia case data so you can close communication gaps between OR, pharmacy, revenue cycle, and clinical teams. Our Insight Engine works in the background, surfacing trends, current issues, and the best next steps for your organization. Medaxion simplifies work for key healthcare personnel, without introducing IT complexity. By design, our products are easy to use and fast. Medaxion’s cloud-based technology drives real-time relay of activity data from clinical staff to a robust management and messaging system. We compile inputs from various sources to deliver relevant information when needed.
To learn more about Medaxion, visit http://www.medaxion.com/
Contact:
Jeff McLaren, Chief Executive Officer
615-537-5500
https://www.linkedin.com/in/jeff-mclaren-9a549132/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.